These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28178721)

  • 21. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
    Alexander HR; Libutti SK; Bartlett DL; Puhlmann M; Fraker DL; Bachenheimer LC
    Clin Cancer Res; 2000 Aug; 6(8):3062-70. PubMed ID: 10955785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study.
    van Etten B; Brunstein F; van IJken MG; Marinelli AW; Verhoef C; van der Sijp JR; Guetens G; de Boeck G; de Bruijn EA; de Wilt JH; Eggermont AM
    Ann Surg Oncol; 2004 Jun; 11(6):598-605. PubMed ID: 15172933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases.
    van Etten B; de Wilt JH; Brunstein F; Eggermont AM; Verhoef C
    Eur J Surg Oncol; 2009 May; 35(5):539-45. PubMed ID: 18760560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of chemosaturation in patients with hepatic metastases from uveal melanoma.
    Estler A; Artzner C; Bitzer M; Nikolaou K; Hoffmann R; Hepp T; Hagen F; Eigentler T; Forschner A; Grözinger G
    Acta Radiol; 2022 May; 63(5):577-585. PubMed ID: 34034537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation perfusion of the liver.
    Carroll NM; Alexander HR
    Cancer J; 2002; 8(2):181-93. PubMed ID: 12004803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemosaturation with Percutaneous Hepatic Perfusion: Outcome and Safety in Patients with Metastasized Uveal Melanoma.
    Dewald CLA; Hinrichs JB; Becker LS; Maschke S; Meine TC; Saborowski A; Schönfeld LJ; Vogel A; Kirstein MM; Wacker FK
    Rofo; 2021 Aug; 193(8):928-936. PubMed ID: 33535258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of isolated hepatic perfusion for patients who have unresectable hepatic malignancies.
    Jones A; Alexander HR
    Surg Oncol Clin N Am; 2008 Oct; 17(4):857-76, x. PubMed ID: 18722923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan.
    Hofmann H; von Haken R; Werner J; Kortes N; Bergmann F; Schemmer P; Jäger D; Radeleff B; Schulze-Bergkamen H
    Pancreatology; 2014; 14(6):546-9. PubMed ID: 25280592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma.
    Modi S; Gibson T; Vigneswaran G; Patel S; Wheater M; Karydis I; Gupta S; Takhar A; Pearce N; Ottensmeier C; Stedman B
    Melanoma Res; 2022 Apr; 32(2):103-111. PubMed ID: 35254333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases; a new simplified technique in isolated hepatic perfusion.
    Verhoef C; de Wilt JH; Brunstein F; Marinelli AW; van Etten B; Vermaas M; Guetens G; de Boeck G; de Bruijn EA; Eggermont AM
    Ann Surg Oncol; 2008 May; 15(5):1367-74. PubMed ID: 18239976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.
    Alexander HR; Libutti SK; Bartlett DL; Pingpank JF; Kranda K; Helsabeck C; Beresnev T
    Cancer; 2002 Aug; 95(4):730-6. PubMed ID: 12209715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
    Meijer TS; Burgmans MC; de Leede EM; de Geus-Oei LF; Boekestijn B; Handgraaf HJM; Hilling DE; Lutjeboer J; Vuijk J; Martini CH; van Erkel AR; van der Meer RW; Tijl FGJ; Speetjens FM; Kapiteijn E; Vahrmeijer AL
    Ann Surg Oncol; 2021 Feb; 28(2):1130-1141. PubMed ID: 32761328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemosaturation of the Liver - an Update.
    Ebel S; Struck MF; van Boemmel F; Beeskow AB; Gößmann H; Denecke T
    Rofo; 2023 Jan; 195(1):30-37. PubMed ID: 35977553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated hepatic perfusion with high-dose melphalan results in immediate alterations in tumor gene expression in patients with metastatic ocular melanoma.
    Varghese S; Xu H; Bartlett D; Hughes M; Pingpank JF; Beresnev T; Alexander HR
    Ann Surg Oncol; 2010 Jul; 17(7):1870-7. PubMed ID: 20221901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiation of Chemosaturation With Percutaneous Hepatic Perfusion Program in Interventional Radiology Department.
    Öcal O; Eldem G; Karagoz AH; Kılıçkap S; Yalcin S; Balkanci F; Peynircioglu B
    Cureus; 2021 Sep; 13(9):e17880. PubMed ID: 34660079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional treatment options for patients with ocular melanoma metastatic to the liver.
    Feldman ED; Pingpank JF; Alexander HR
    Ann Surg Oncol; 2004 Mar; 11(3):290-7. PubMed ID: 14993024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option.
    Dewald CLA; Becker LS; Meine TC; Maschke SK; Wacker FK; Saborowski A; Vogel A; Hinrichs JB
    Clin Exp Metastasis; 2023 Feb; 40(1):95-104. PubMed ID: 36417096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer.
    Bartlett DL; Libutti SK; Figg WD; Fraker DL; Alexander HR
    Surgery; 2001 Feb; 129(2):176-87. PubMed ID: 11174711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.
    Meijer TS; Geus-Oei LF; Martini CH; Tijl FGJ; Sitsen ME; Erkel ARV; Meer RWV; Kapiteijn E; Vahrmeijer AL; Burgmans MC
    Diagn Interv Radiol; 2019 Nov; 25(6):451-458. PubMed ID: 31650973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of melanoma metastases confined to the liver and future perspectives.
    Vahrmeijer AL; van de Velde CJ; Hartgrink HH; Tollenaar RA
    Dig Surg; 2008; 25(6):467-72. PubMed ID: 19212119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.